Zobrazeno 1 - 2
of 2
pro vyhledávání: '"on behalf of the OPTIC study group"'
Autor:
S. R. M. Bus, L. Zambreanu, A. Abbas, Y. A. Rajabally, R. D. M. Hadden, R. J. de Haan, C. A. J. M. de Borgie, M. P. Lunn, I. N. van Schaik, F. Eftimov, on behalf of the OPTIC study group
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-18 (2021)
Abstract Background International guidelines recommend either intravenous immunoglobulin (IVIg) or corticosteroids as first-line treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). IVIg treatment usually leads to rapid imp
Externí odkaz:
https://doaj.org/article/86106c2f745f4ee7aa575fbdc28612b9
Autor:
Bus, S. R. M., Zambreanu, L., Abbas, A., Rajabally, Y. A., Hadden, R. D. M., de Haan, R. J., de Borgie, C. A. J. M., Lunn, M. P., van Schaik, I. N., Eftimov, F., on behalf of the OPTIC study group, Vrancken, A. F. J. E., van Doorn, P. A., Hoeijmakers, J. G. J., Voermans, N., Wirtz, P. W., Padberg, M., de Rijk, M., Chavada, G., Miller, J.
Publikováno v:
Trials; 2/19/2021, Vol. 22 Issue 1, p1-18, 18p, 2 Charts, 1 Graph